Latest Contracts News

RBR Group Limited is strategically positioning itself to capitalise on the restart of major LNG projects in Mozambique, advancing joint ventures and raising capital to meet anticipated demand.

Macro Metals Limited has secured two non-binding letters of intent from licensed Singaporean importers for trial shipments of up to 600,000 cubic meters of sand from its Port Hedland deposit, marking a significant step in its export ambitions.

Avenira Limited has advanced its Wonarah Phosphate Project with Northern Territory Government approval of its Mine Management Plan and secured $7.57 million through a placement to Hebang, while deferring operational start to optimize costs.

Celsius Resources has launched an updated feasibility study and front-end engineering design for its flagship MCB Copper-Gold Project, backed by a $76.4 million bridge loan from the Philippine sovereign wealth fund. The company also raised A$1.7 million in equity and progressed environmental and social initiatives across its portfolio.

IMEXHS Limited reported steady Q2 FY25 revenue with an 11% rise in annual recurring revenue, supported by a $2.6 million capital raise and operational advances including a major Mexican contract win.

Alvo Minerals has progressed multiple prospects at its Palma Copper-Zinc Project in Brazil, secured $1.56 million through an entitlement offer, and expanded its mining services division, positioning itself for growth.

Swift Networks reports positive FY25 cash flow and EBITDA, secures new mining contracts, and progresses its next-generation Swift Access 2026 platform poised to accelerate growth.

Cann Group Limited delivered record production and revenue growth in Q4 FY2025, securing new funding and advancing a major debt restructuring to set the stage for profitability in FY2026.

Clarity Pharmaceuticals has bolstered its cash reserves to approximately $288 million following a $203 million institutional placement, while reporting significant clinical progress across multiple copper-based radiopharmaceutical trials targeting prostate cancer and neuroendocrine tumours.

Delorean Corporation has marked significant progress in Q4 FY2025, advancing its renewable gas infrastructure and securing crucial regulatory support that could unlock new revenue streams.

Carbonxt Group Limited advances its Kentucky activated carbon facility with increased ownership and imminent kiln commissioning, while securing $1 million in convertible notes to support growth. The company reports steady revenue and strong market positioning amid tightening US EPA PFAS regulations.

Cambium Bio has cleared key regulatory hurdles for its lead dry eye disease treatment, Elate Ocular, and strengthened its balance sheet with a $2.12 million placement to support upcoming Phase 3 trials.